Potential association between IL-12/23, IL-23, and IL-17 inhibitors and skin cancer: a pharmacovigilance study based on the FAERS database

Xing Jiang, Yunbei Huang, Min Xie, Li Peng, Mengyao Xu, Zhongyu Qi, Guojun Wang, Xiaofeng Pu

Open source

DOI
10.3389/fphar.2026.1944368
Published
2026-10-22
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1944368,
  title = {Potential association between IL-12/23, IL-23, and IL-17 inhibitors and skin cancer: a pharmacovigilance study based on the FAERS database},
  author = {Xing Jiang and Yunbei Huang and Min Xie and Li Peng and Mengyao Xu and Zhongyu Qi and Guojun Wang and Xiaofeng Pu},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1944368},
  url = {https://doi.org/10.3389/fphar.2026.1944368}
}

RIS

TY  - JOUR
TI  - Potential association between IL-12/23, IL-23, and IL-17 inhibitors and skin cancer: a pharmacovigilance study based on the FAERS database
AU  - Xing Jiang
AU  - Yunbei Huang
AU  - Min Xie
AU  - Li Peng
AU  - Mengyao Xu
AU  - Zhongyu Qi
AU  - Guojun Wang
AU  - Xiaofeng Pu
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1944368
UR  - https://doi.org/10.3389/fphar.2026.1944368
ER  - 

APA

Jiang, X., Huang, Y., Xie, M., Peng, L., Xu, M., Qi, Z., Wang, G., & Pu, X. (2026). Potential association between IL-12/23, IL-23, and IL-17 inhibitors and skin cancer: a pharmacovigilance study based on the FAERS database. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1944368

Source records